Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2006 by Medical University of Vienna.
Recruitment status was Active, not recruiting

Study NCT00261612 Information provided by Medical University of Vienna

First Received on December 1, 2005. Last Updated on October 17, 2006 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Lymphoma

More general conditions related to this trial

Interventions listed in this trial

bortezomib
rituximab
dexamethasone
treatment protocol

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial